The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome
Jun Li, Rui Shan, Heather Miller, Alexander Filatov, Maria G Byazrova, Lu Yang, Chaohong Liu
Cell Insight, doi:10.1016/j.cellin.2025.100250
The global COVID-19 pandemic has highlighted the pivotal role of the immune system in the development of severe respiratory symptoms, termed COVID-19 Severe Respiratory Syndrome . This review aims to dissect the involvement of lung macrophages and monocytes in orchestrating immune responses to SARS-CoV-2, influencing disease severity and outcomes. Initially, we provide an overview of SARS-CoV-2's invasion process and the body's primary immune defense mechanisms, including the antibody complement system and cytokine production. We then delve into the roles of the monocyte-macrophage system in mediating hyperinflammation and cytokine storms, discussing how abnormal cytokine and chemokine levels contribute to disease progression. Subsequent sections examine the perturbations and overactivation of the monocyte-macrophage compartment during infection, linking these changes to the observed immune dysregulation in COVID-19 patients. In light of these insights, we explore therapeutic strategies targeting macrophages, such as dexamethasone, antisense lipid nanoparticles(ALN), and inhaled recombinant human granulocyte-macrophage colony-stimulating factor (rh-GM-CSF), which aim to modulate inflammation, suppress viral replication, and enhance viral clearance. Additional potential treatments include GSDMD inhibitors and GPR183 antagonists, which warrant further investigation. This review synthesizes current understanding of the immunopathology underlying COVID-19-SR, proposing macrophage-and monocyte-centered therapeutic avenues and outlining future research priorities essential for advancing clinical management and improving patient outcomes.
Conflict of interest There are no conflicts of interest in this study. All authors have read and approved this version of the article, and due care has been taken to ensure the integrity of the work. Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal.
References
Andreakos, Zanoni, Galani, Lambda interferons come to light: Dual function cytokines mediating antiviral immunity and damage control, Current Opinion in Immunology,
doi:10.1016/j.coi.2018.10.007Bernal, Gomes Da Silva, Musungaie, Kovalchuk, Gonzalez et al., Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients, New England Journal of Medicine,
doi:10.1056/NEJMoa2116044Blanco-Melo, Nilsson-Payant, Liu, Uhl, Hoagland et al., Imbalanced host response to SARS-CoV-2 drives development of COVID-19, Cell,
doi:10.1016/j.cell.2020.04.026Boechat, Chora, Morais, Delgado, The immune response to SARS-CoV-2 and COVID-19 immunopathology-current perspectives, Pulmonology,
doi:10.1016/j.pulmoe.2021.03.008Bosteels, Van Damme, De Leeuw, Declercq, Maes et al., Loss of GM-CSFdependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment, Cell Reports Medicine,
doi:10.1016/j.xcrm.2022.100833Boudewijns, Thibaut, Kaptein, Li, Vergote et al., STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters, Nature Communications,
doi:10.1038/s41467-020-19684-yBouvet, Debarnot, Imbert, Selisko, Snijder et al., In vitro reconstitution of SARS-coronavirus mRNA cap methylation, PLoS Pathogens,
doi:10.1371/journal.ppat.1000863Bryce, Grimes, Pujadas, Ahuja, Beasley et al., Pathophysiology of SARS-CoV-2: Targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response, The Mount Sinai COVID,
doi:10.1101/2020.05.18.20099960Cantuti-Castelvetri, Ojha, Pedro, Djannatian, Franz et al., Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity, Science,
doi:10.1126/science.abd2985Chauhan, Kaur, Chakrbarti, Pal, Silent hypoxemia" leads to vicious cycle of infection, coagulopathy and cytokine storm in COVID-19: Can prophylactic oxygen therapy prevent it?, Indian Journal of Clinical Biochemistry,
doi:10.1007/s12291-021-00967-0Chen, Park, Del Valle, Buckup, Tabachnikova et al., A shift in lung macrophage composition is associated with COVID-19 severity and recovery, Science Translational Medicine,
doi:10.1126/scitranslmed.abn5168Chen, Wu, Guo, Cao, Huang et al., Clinical and immunological features of severe and moderate coronavirus disease 2019, Journal of Clinical Investigation,
doi:10.1172/JCI137244Chen, Zhou, Dong, Qu, Gong et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: A descriptive study, Lancet,
doi:10.1016/S0140-6736(20)30211-7Chiok, Hutchison, Miller, Bose, Miura, Proinflammatory responses in SARS-CoV-2 and soluble spike glycoprotein S1 subunit activated human macrophages, Viruses,
doi:10.3390/v15030754Chuquimia, Petursdottir, Periolo, Fern Andez, Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth, Infection and Immunity,
doi:10.1128/iai.00950-12Clausen, Sandoval, Spliid, Pihl, Perrett et al., SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2, Cell,
doi:10.1016/j.cell.2020.09.033Codo, Davanzo, De Brito Monteiro, De Souza, Muraro et al., Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/Glycolysis-Dependent Axis, Cell Metabolism,
doi:10.1016/j.cmet.2020.07.007Conti, Caraffa, Gallenga, Ross, Kritas et al., Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: A promising inhibitory strategy, Journal of Biological Regulators & Homeostatic Agents,
doi:10.1038/s41586-021-03767-xDougan, Nirula, Azizad, Mocherla, Gottlieb et al., Bamlanivimab plus etesevimab in mild or moderate Covid-19, New England Journal of Medicine,
doi:10.1056/NEJMoa2102685Foo, Bartlett, Chew, Ngo, Bielefeldt-Ohmann et al., GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection, European Respiratory Journal,
doi:10.1183/13993003.01306-2022Fu, Wang, Yuan, Chen, Ao et al., Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis, Journal of Infection,
doi:10.1016/j.jinf.2020.03.041Galani, Triantafyllia, Eleminiadou, Koltsida, Stavropoulos et al., Interferon-λ mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness, Immunity,
doi:10.1016/j.immuni.2017.04.025Garcia-Beltran, Lam, Astudillo, Yang, Miller et al., COVID-19neutralizing antibodies predict disease severity and survival, Cell,
doi:10.1016/j.cell.2020.12.015Grant, Morales-Nebreda, Markov, Swaminathan, Querrey et al., Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia, Nature,
doi:10.1038/s41586-020-03148-wGuan, Ni, Hu, Liang, Ou et al., Clinical characteristics of coronavirus disease 2019 in China, New England Journal of Medicine,
doi:10.1056/NEJMoa2002032Gusev, Sarapultsev, Solomatina, Chereshnev, SARS-CoV-2-specific immune response and the pathogenesis of COVID-19, International Journal of Molecular Sciences,
doi:10.3390/ijms23031716Hammond, Leister-Tebbe, Gardner, Abreu, Bao et al., Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19, New England Journal of Medicine,
doi:10.1056/NEJMoa2118542He, Ding, Zhang, Che, He et al., Expression of elevated levels of pro-inflammatory cytokines in SARS-CoVinfected ACE2þ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS, The Journal of Pathology,
doi:10.1002/path.2067Hoepel, Chen, Geyer, Allahverdiyeva, Manz et al., High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages, Science Translational Medicine,
doi:10.1126/scitranslmed.abf8654Idiz, Yurttas, Degirmencioglu, Orhan, Erdogan et al., Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients, Journal of Medical Virology,
doi:10.1002/jmv.27917Junqueira, Crespo, Ranjbar, De Lacerda, Lewandrowski et al., FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation, Nature,
doi:10.1038/s41586-022-04702-4Kamitani, Huang, Narayanan, Lokugamage, Makino, A twopronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein, Nature Structural & Molecular Biology,
doi:10.1038/nsmb1130Klinkhammer, Schnepf, Ye, Schwaderlapp, Gad et al., IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission, Elife,
doi:10.7554/elife.33354Kousathanas, Pairo-Castineira, Rawlik, Stuckey, Odhams et al., Whole-genome sequencing reveals host factors underlying critical COVID-19, Nature,
doi:10.1038/s41586-022-04576-6Larsen, De Graaf, Sonneveld, Plomp, Nouta et al., Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity, Science,
doi:10.1126/science.abc8378Li, Huang, Wu, Zhong, Li et al., Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19, Nature Communications,
doi:10.1038/s41467-020-19943-yLiao, Liu, Yuan, Wen, Xu et al., Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Nature Medicine,
doi:10.1038/s41591-020-0901-9Liu, Xia, Zhang, Wu, Lieberman, Channelling inflammation: Gasdermins in physiology and disease, Nature Reviews Drug Discovery,
doi:10.1038/s41573-021-00154-zLokugamage, Hage, Schindewolf, Rajsbaum, Menachery, SARS-CoV-2 is sensitive to type I interferon pretreatment, Nature Microbiology,
doi:10.1101/2020.03.07.982264Meidaninikjeh, Sabouni, Marzouni, Bengar, Khalili et al., Monocytes and macrophages in COVID-19: Friends and foes, Life Sciences,
doi:10.1016/j.lfs.2021.119129Miorin, Kehrer, Sanchez-Aparicio, SARS-CoV-2 ORF6 antagonizes interferon signaling by sequestering STAT1 and STAT2 in the endoplasmic reticulum, Nature Communications,
doi:10.1038/s41467-020-18935-2Oosterhoff, Larsen, Van Der Schoot, Vidarsson, Afucosylated IgG responses in humans-structural clues to the regulation of humoral immunity, Trends in Immunology,
doi:10.1016/j.it.2022.08.001Pairo-Castineira, Clohisey, Klaric, Bretherick, Rawlik et al., Genetic mechanisms of critical illness in COVID-19, Nature,
doi:10.1038/s41586-020-03065-yPan, Shen, Yu, Ge, Chen et al., SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation, Nature Communications,
doi:10.1038/s41467-021-25015-6Park, Iwasaki, Type I and type III interferons-induction, signaling, evasion, and application to combat COVID-19, Cell Host & Microbe,
doi:10.1016/j.chom.2020.05.008Pechkovsky, Goldmann, Ludwig, Prasse, Vollmer et al., CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II, Respiratory Research,
doi:10.1186/1465-9921-6-75Qin, Zhou, Hu, Zhang, Yang et al., Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China, Clinical Infectious Diseases,
doi:10.1093/cid/ciaa248Reyfman, Walter, Joshi, Anekalla, Mcquattie-Pimentel et al., Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis, American Journal of Respiratory and Critical Care Medicine,
doi:10.1164/rccm.201712-2410ocRogers, Erkes, Nardone, Aplin, Fernandes-Alnemri et al., Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation, Nature Communications,
doi:10.1038/s41467-019-09397-2Ruan, Yang, Wang, Jiang, Song, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Medicine,
doi:10.1007/s00134-020-05991-xSchifanella, Anderson, Galli, Corbellino, Lai et al., Massive viral replication and cytopathic effects in early COVID-19 pneumonia,
doi:10.48550/arXiv.2005.00004Sharma, Kanneganti, The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation, The Journal of Cell Biology,
doi:10.1083/jcb.201602089Song, Hu, Yu, Zhao, Zhao et al., Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages, Cytometry, Part A,
doi:10.1002/cyto.a.24285Sun, Xie, Bu, Zhong, Zeng, Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants, Signal Transduction and Targeted Therapy,
doi:10.1038/s41392-022-01039-2Suryawanshi, Chen, Ma, Syed, Brazer et al., Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination, Nature,
doi:10.1038/s41586-022-04865-0Upadhyay, Viox, Hoang, Boddapati, Pino et al., TREM2þ and interstitiallike macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques, Nature Communications,
doi:10.1038/s41467-023-37425-9Valle, Kim-Schulze, Huang, Beckmann, Nirenberg et al., An inflammatory cytokine signature predicts COVID-19 severity and survival, Nature Medicine,
doi:10.1038/s41591-020-1051-9Wang, Guo, Fan, Han, Zhang et al., Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivors, Chin. Med. J. Pulm. Crit. Care Med,
doi:10.1016/j.pccm.2024.02.005Wang, Xie, Zhao, Fei, Zhang et al., Alveolar macrophage activation and polarization in COVID-19: A systematic review of the current evidence, Frontiers in Immunology,
doi:10.3389/fimmu.2021.620287Wang, Zhan, Zhu, Hou, Liu et al., Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients, Cell Host & Microbe,
doi:10.1016/j.chom.2020.07.005Wang, Zhou, Bao, Li, Lv et al., Airway administration of bisphosphate and dexamethasone inhibits SARS-CoV-2 variant infection by targeting alveolar macrophages, Signal Transduction and Targeted Therapy,
doi:10.1038/s41392-022-00977-1Weber, Wagner, Rasmussen, Hartmann, Paludan, Doublestranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses, Journal of Virology,
doi:10.1128/jvi.80.10.5059-5064.2006Wu, Chen, Cai, Zhou, Xu et al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Internal Medicine,
doi:10.1001/jamainternmed.2020.0994Xiong, Ma, Liu, Tong, Huang et al., ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses, Cell Insight,
doi:10.1016/j.cellin.2023.100145Yap, Moriyama, Iwasaki, Inflammasomes and pyroptosis as therapeutic targets for COVID-19, The Journal of Immunology,
doi:10.4049/jimmunol.2000513Ye, Schnepf, Staeheli, Interferon-λ orchestrates innate and adaptive mucosal immune responses, Nature Reviews Immunology,
doi:10.1038/s41577-019-0182-zZeng, Liu, Ma, Zhao, Yang et al., Biochemical characterization of SARS-CoV-2 nucleocapsid protein, Biochemical and Biophysical Research Communications,
doi:10.1016/j.bbrc.2020.04.136Zhang, Zhou, Wei, Yue, Wang et al., Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19, Annals of Internal Medicine,
doi:10.7326/M20-0533Zheng, Peng, Zhou, Pulmonary fibrosis: A short-or long-term sequelae of severe COVID-19? Chin, Med. J. Pulm. Crit. Care Med,
doi:10.1016/j.pccm.2022.12.002Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: A retrospective cohort study, Lancet,
doi:10.1016/S0140-6736(20)30566-3Zhu, Chen, Yan, Jiang, Liu et al., Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs, Nature Immunology,
doi:10.1038/s41590-024-02072-9DOI record:
{
"DOI": "10.1016/j.cellin.2025.100250",
"ISSN": [
"2772-8927"
],
"URL": "http://dx.doi.org/10.1016/j.cellin.2025.100250",
"alternative-id": [
"S2772892725000240"
],
"article-number": "100250",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "Cell Insight"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.cellin.2025.100250"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2025 The Authors. Published by Elsevier B.V. on behalf of Wuhan University."
}
],
"author": [
{
"ORCID": "https://orcid.org/0009-0007-7862-1316",
"affiliation": [],
"authenticated-orcid": false,
"family": "Li",
"given": "Jun",
"sequence": "first"
},
{
"affiliation": [],
"family": "Shan",
"given": "Rui",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Miller",
"given": "Heather",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-6460-9427",
"affiliation": [],
"authenticated-orcid": false,
"family": "Filatov",
"given": "Alexander",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0002-9858-7596",
"affiliation": [],
"authenticated-orcid": false,
"family": "Byazrova",
"given": "Maria G.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Yang",
"given": "Lu",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Liu",
"given": "Chaohong",
"sequence": "additional"
}
],
"container-title": "Cell Insight",
"container-title-short": "Cell Insight",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2025,
5,
8
]
],
"date-time": "2025-05-08T17:59:47Z",
"timestamp": 1746727187000
},
"deposited": {
"date-parts": [
[
2025,
7,
15
]
],
"date-time": "2025-07-15T14:59:26Z",
"timestamp": 1752591566000
},
"indexed": {
"date-parts": [
[
2025,
7,
16
]
],
"date-time": "2025-07-16T00:08:10Z",
"timestamp": 1752624490047,
"version": "3.41.2"
},
"is-referenced-by-count": 0,
"issue": "4",
"issued": {
"date-parts": [
[
2025,
8
]
]
},
"journal-issue": {
"issue": "4",
"published-print": {
"date-parts": [
[
2025,
8
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
8,
1
]
],
"date-time": "2025-08-01T00:00:00Z",
"timestamp": 1754006400000
}
},
{
"URL": "https://www.elsevier.com/legal/tdmrep-license",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
8,
1
]
],
"date-time": "2025-08-01T00:00:00Z",
"timestamp": 1754006400000
}
},
{
"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
5,
6
]
],
"date-time": "2025-05-06T00:00:00Z",
"timestamp": 1746489600000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S2772892725000240?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S2772892725000240?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "100250",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2025,
8
]
]
},
"published-print": {
"date-parts": [
[
2025,
8
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/j.coi.2018.10.007",
"article-title": "Lambda interferons come to light: Dual function cytokines mediating antiviral immunity and damage control",
"author": "Andreakos",
"doi-asserted-by": "crossref",
"first-page": "67",
"journal-title": "Current Opinion in Immunology",
"key": "10.1016/j.cellin.2025.100250_bib1",
"volume": "56",
"year": "2019"
},
{
"DOI": "10.1016/j.cell.2020.04.026",
"article-title": "Imbalanced host response to SARS-CoV-2 drives development of COVID-19",
"author": "Blanco-Melo",
"doi-asserted-by": "crossref",
"first-page": "1036",
"issue": "5",
"journal-title": "Cell",
"key": "10.1016/j.cellin.2025.100250_bib2",
"volume": "181",
"year": "2020"
},
{
"DOI": "10.1016/j.pulmoe.2021.03.008",
"article-title": "The immune response to SARS-CoV-2 and COVID-19 immunopathology-current perspectives",
"author": "Boechat",
"doi-asserted-by": "crossref",
"first-page": "423",
"issue": "5",
"journal-title": "Pulmonology",
"key": "10.1016/j.cellin.2025.100250_bib3",
"volume": "27",
"year": "2021"
},
{
"DOI": "10.1016/j.xcrm.2022.100833",
"article-title": "Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment",
"author": "Bosteels",
"doi-asserted-by": "crossref",
"issue": "12",
"journal-title": "Cell Reports Medicine",
"key": "10.1016/j.cellin.2025.100250_bib4",
"volume": "3",
"year": "2022"
},
{
"DOI": "10.1038/s41467-020-19684-y",
"article-title": "STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters",
"author": "Boudewijns",
"doi-asserted-by": "crossref",
"first-page": "5838",
"issue": "1",
"journal-title": "Nature Communications",
"key": "10.1016/j.cellin.2025.100250_bib5",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1371/journal.ppat.1000863",
"article-title": "In vitro reconstitution of SARS-coronavirus mRNA cap methylation",
"author": "Bouvet",
"doi-asserted-by": "crossref",
"issue": "4",
"journal-title": "PLoS Pathogens",
"key": "10.1016/j.cellin.2025.100250_bib6",
"volume": "6",
"year": "2010"
},
{
"DOI": "10.1111/imr.12350",
"article-title": "Mouse and human FcR effector functions",
"author": "Bruhns",
"doi-asserted-by": "crossref",
"first-page": "25",
"issue": "1",
"journal-title": "Immunological Reviews",
"key": "10.1016/j.cellin.2025.100250_bib7",
"volume": "268",
"year": "2015"
},
{
"article-title": "Pathophysiology of SARS-CoV-2: Targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response",
"author": "Bryce",
"journal-title": "The Mount Sinai COVID-19 autopsy experience",
"key": "10.1016/j.cellin.2025.100250_bib8",
"year": "2020"
},
{
"DOI": "10.1126/science.abd2985",
"article-title": "Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity",
"author": "Cantuti-Castelvetri",
"doi-asserted-by": "crossref",
"first-page": "856",
"issue": "6518",
"journal-title": "Science",
"key": "10.1016/j.cellin.2025.100250_bib9",
"volume": "370",
"year": "2020"
},
{
"DOI": "10.1038/s41577-020-0308-3",
"article-title": "COVID-19: Immunopathology and its implications for therapy",
"author": "Cao",
"doi-asserted-by": "crossref",
"first-page": "269",
"issue": "5",
"journal-title": "Nature Reviews Immunology",
"key": "10.1016/j.cellin.2025.100250_bib10",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.1007/s12291-021-00967-0",
"article-title": "“Silent hypoxemia” leads to vicious cycle of infection, coagulopathy and cytokine storm in COVID-19: Can prophylactic oxygen therapy prevent it?",
"author": "Chauhan",
"doi-asserted-by": "crossref",
"first-page": "468",
"issue": "4",
"journal-title": "Indian Journal of Clinical Biochemistry",
"key": "10.1016/j.cellin.2025.100250_bib11",
"volume": "36",
"year": "2021"
},
{
"DOI": "10.1016/j.bj.2022.04.006",
"article-title": "SARS-CoV-2 variants--evolution, spike protein, and vaccines",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "573",
"issue": "4",
"journal-title": "Biomedical Journal",
"key": "10.1016/j.cellin.2025.100250_bib12",
"volume": "45",
"year": "2022"
},
{
"DOI": "10.1126/scitranslmed.abn5168",
"article-title": "A shift in lung macrophage composition is associated with COVID-19 severity and recovery",
"author": "Chen",
"doi-asserted-by": "crossref",
"issue": "662",
"journal-title": "Science Translational Medicine",
"key": "10.1016/j.cellin.2025.100250_bib13",
"volume": "14",
"year": "2022"
},
{
"DOI": "10.1172/JCI137244",
"article-title": "Clinical and immunological features of severe and moderate coronavirus disease 2019",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "2620",
"issue": "5",
"journal-title": "Journal of Clinical Investigation",
"key": "10.1016/j.cellin.2025.100250_bib14",
"volume": "130",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)30211-7",
"article-title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: A descriptive study",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "507",
"issue": "10223",
"journal-title": "Lancet",
"key": "10.1016/j.cellin.2025.100250_bib15",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.3390/v15030754",
"article-title": "Proinflammatory responses in SARS-CoV-2 and soluble spike glycoprotein S1 subunit activated human macrophages",
"author": "Chiok",
"doi-asserted-by": "crossref",
"first-page": "754",
"issue": "3",
"journal-title": "Viruses",
"key": "10.1016/j.cellin.2025.100250_bib16",
"volume": "15",
"year": "2023"
},
{
"DOI": "10.1128/IAI.00950-12",
"article-title": "Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth",
"author": "Chuquimia",
"doi-asserted-by": "crossref",
"first-page": "381",
"issue": "1",
"journal-title": "Infection and Immunity",
"key": "10.1016/j.cellin.2025.100250_bib17",
"volume": "81",
"year": "2013"
},
{
"DOI": "10.1016/j.cell.2020.09.033",
"article-title": "SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2",
"author": "Clausen",
"doi-asserted-by": "crossref",
"first-page": "1043",
"issue": "4",
"journal-title": "Cell",
"key": "10.1016/j.cellin.2025.100250_bib18",
"volume": "183",
"year": "2020"
},
{
"DOI": "10.1016/j.cmet.2020.07.007",
"article-title": "Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/Glycolysis-Dependent Axis",
"author": "Codo",
"doi-asserted-by": "crossref",
"first-page": "437",
"issue": "3",
"journal-title": "Cell Metabolism",
"key": "10.1016/j.cellin.2025.100250_bib19",
"volume": "32",
"year": "2020"
},
{
"DOI": "10.23812/20-1-E",
"article-title": "Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: A promising inhibitory strategy",
"author": "Conti",
"doi-asserted-by": "crossref",
"first-page": "1971",
"issue": "6",
"journal-title": "Journal of Biological Regulators & Homeostatic Agents",
"key": "10.1016/j.cellin.2025.100250_bib20",
"volume": "34",
"year": "2020"
},
{
"DOI": "10.1038/s41586-021-03767-x",
"article-title": "Mapping the human genetic architecture of COVID-19",
"doi-asserted-by": "crossref",
"first-page": "472",
"journal-title": "Nature",
"key": "10.1016/j.cellin.2025.100250_bib21",
"volume": "600",
"year": "2021"
},
{
"DOI": "10.1038/s41591-020-1051-9",
"article-title": "An inflammatory cytokine signature predicts COVID-19 severity and survival",
"author": "Del Valle",
"doi-asserted-by": "crossref",
"first-page": "1636",
"issue": "10",
"journal-title": "Nature Medicine",
"key": "10.1016/j.cellin.2025.100250_bib22",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1016/j.cellin.2023.100144",
"article-title": "Development of SARS-CoV-2 entry antivirals",
"author": "Dong",
"doi-asserted-by": "crossref",
"issue": "1",
"journal-title": "Cell Insight",
"key": "10.1016/j.cellin.2025.100250_bib23",
"volume": "3",
"year": "2024"
},
{
"DOI": "10.1056/NEJMoa2102685",
"article-title": "Bamlanivimab plus etesevimab in mild or moderate Covid-19",
"author": "Dougan",
"doi-asserted-by": "crossref",
"first-page": "1382",
"issue": "15",
"journal-title": "New England Journal of Medicine",
"key": "10.1016/j.cellin.2025.100250_bib24",
"volume": "385",
"year": "2021"
},
{
"DOI": "10.1128/IAI.73.4.1907-1916.2005",
"article-title": "Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells",
"author": "Fink",
"doi-asserted-by": "crossref",
"first-page": "1907",
"issue": "4",
"journal-title": "Infection and Immunity",
"key": "10.1016/j.cellin.2025.100250_bib25",
"volume": "73",
"year": "2005"
},
{
"DOI": "10.1183/13993003.01306-2022",
"article-title": "GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection",
"author": "Foo",
"doi-asserted-by": "crossref",
"issue": "3",
"journal-title": "European Respiratory Journal",
"key": "10.1016/j.cellin.2025.100250_bib26",
"volume": "61",
"year": "2023"
},
{
"DOI": "10.1016/j.jinf.2020.03.041",
"article-title": "Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis",
"author": "Fu",
"doi-asserted-by": "crossref",
"first-page": "656",
"issue": "6",
"journal-title": "Journal of Infection",
"key": "10.1016/j.cellin.2025.100250_bib27",
"volume": "80",
"year": "2020"
},
{
"DOI": "10.1016/j.immuni.2017.04.025",
"article-title": "Interferon-λ mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness",
"author": "Galani",
"doi-asserted-by": "crossref",
"first-page": "875",
"issue": "5",
"journal-title": "Immunity",
"key": "10.1016/j.cellin.2025.100250_bib28",
"volume": "46",
"year": "2017"
},
{
"DOI": "10.1016/j.cell.2020.12.015",
"article-title": "COVID-19-neutralizing antibodies predict disease severity and survival",
"author": "Garcia-Beltran",
"doi-asserted-by": "crossref",
"first-page": "476",
"issue": "2",
"journal-title": "Cell",
"key": "10.1016/j.cellin.2025.100250_bib29",
"volume": "184",
"year": "2021"
},
{
"DOI": "10.1038/s41586-020-03148-w",
"article-title": "Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia",
"author": "Grant",
"doi-asserted-by": "crossref",
"first-page": "635",
"issue": "7847",
"journal-title": "Nature",
"key": "10.1016/j.cellin.2025.100250_bib30",
"volume": "590",
"year": "2021"
},
{
"DOI": "10.1056/NEJMoa2002032",
"article-title": "Clinical characteristics of coronavirus disease 2019 in China",
"author": "Guan",
"doi-asserted-by": "crossref",
"first-page": "1708",
"issue": "18",
"journal-title": "New England Journal of Medicine",
"key": "10.1016/j.cellin.2025.100250_bib31",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.3390/ijms23031716",
"article-title": "SARS-CoV-2-specific immune response and the pathogenesis of COVID-19",
"author": "Gusev",
"doi-asserted-by": "crossref",
"first-page": "1716",
"issue": "3",
"journal-title": "International Journal of Molecular Sciences",
"key": "10.1016/j.cellin.2025.100250_bib32",
"volume": "23",
"year": "2022"
},
{
"DOI": "10.1016/j.ajpath.2020.08.009",
"article-title": "Immunopathology of hyperinflammation in COVID-19",
"author": "Gustine",
"doi-asserted-by": "crossref",
"first-page": "4",
"issue": "1",
"journal-title": "American Journal of Pathology",
"key": "10.1016/j.cellin.2025.100250_bib33",
"volume": "191",
"year": "2021"
},
{
"DOI": "10.1056/NEJMoa2118542",
"article-title": "Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19",
"author": "Hammond",
"doi-asserted-by": "crossref",
"first-page": "1397",
"issue": "15",
"journal-title": "New England Journal of Medicine",
"key": "10.1016/j.cellin.2025.100250_bib34",
"volume": "386",
"year": "2022"
},
{
"DOI": "10.1002/path.2067",
"article-title": "Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: Relation to the acute lung injury and pathogenesis of SARS",
"author": "He",
"doi-asserted-by": "crossref",
"first-page": "288",
"issue": "3",
"journal-title": "The Journal of Pathology",
"key": "10.1016/j.cellin.2025.100250_bib35",
"volume": "210",
"year": "2006"
},
{
"DOI": "10.1016/S0140-6736(20)30374-3",
"article-title": "COVID-19: What is next for public health?",
"author": "Heymann",
"doi-asserted-by": "crossref",
"first-page": "542",
"issue": "10224",
"journal-title": "Lancet",
"key": "10.1016/j.cellin.2025.100250_bib36",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1126/scitranslmed.abf8654",
"article-title": "High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages",
"author": "Hoepel",
"doi-asserted-by": "crossref",
"issue": "596",
"journal-title": "Science Translational Medicine",
"key": "10.1016/j.cellin.2025.100250_bib37",
"volume": "13",
"year": "2021"
},
{
"DOI": "10.1016/S0140-6736(20)30183-5",
"article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
"author": "Huang",
"doi-asserted-by": "crossref",
"first-page": "497",
"issue": "10223",
"journal-title": "Lancet",
"key": "10.1016/j.cellin.2025.100250_bib38",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1002/jmv.27917",
"article-title": "Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients",
"author": "Idiz",
"doi-asserted-by": "crossref",
"first-page": "4744",
"issue": "10",
"journal-title": "Journal of Medical Virology",
"key": "10.1016/j.cellin.2025.100250_bib39",
"volume": "94",
"year": "2022"
},
{
"DOI": "10.1056/NEJMoa2116044",
"article-title": "Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients",
"author": "Jayk Bernal",
"doi-asserted-by": "crossref",
"first-page": "509",
"issue": "6",
"journal-title": "New England Journal of Medicine",
"key": "10.1016/j.cellin.2025.100250_bib40",
"volume": "386",
"year": "2022"
},
{
"DOI": "10.1038/s41586-022-04702-4",
"article-title": "FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation",
"author": "Junqueira",
"doi-asserted-by": "crossref",
"first-page": "576",
"issue": "7914",
"journal-title": "Nature",
"key": "10.1016/j.cellin.2025.100250_bib41",
"volume": "606",
"year": "2022"
},
{
"article-title": "A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein",
"author": "Kamitani",
"first-page": "751",
"issue": "9",
"journal-title": "Nature Structural & Molecular Biology",
"key": "10.1016/j.cellin.2025.100250_bib42",
"volume": "13",
"year": "2006"
},
{
"DOI": "10.7554/eLife.33354",
"article-title": "IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission",
"author": "Klinkhammer",
"doi-asserted-by": "crossref",
"journal-title": "Elife",
"key": "10.1016/j.cellin.2025.100250_bib44",
"volume": "7",
"year": "2018"
},
{
"DOI": "10.3389/fimmu.2021.720109",
"article-title": "Monocytes and macrophages in COVID-19",
"author": "Knoll",
"doi-asserted-by": "crossref",
"journal-title": "Frontiers in Immunology",
"key": "10.1016/j.cellin.2025.100250_bib45",
"volume": "12",
"year": "2021"
},
{
"DOI": "10.1038/s41586-022-04576-6",
"article-title": "Whole-genome sequencing reveals host factors underlying critical COVID-19",
"author": "Kousathanas",
"doi-asserted-by": "crossref",
"first-page": "97",
"journal-title": "Nature",
"key": "10.1016/j.cellin.2025.100250_bib46",
"volume": "607",
"year": "2022"
},
{
"DOI": "10.1126/science.abc8378",
"article-title": "Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity",
"author": "Larsen",
"doi-asserted-by": "crossref",
"issue": "6532",
"journal-title": "Science",
"key": "10.1016/j.cellin.2025.100250_bib47",
"volume": "371",
"year": "2021"
},
{
"DOI": "10.1038/s41467-020-19943-y",
"article-title": "Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "6044",
"issue": "1",
"journal-title": "Nature Communications",
"key": "10.1016/j.cellin.2025.100250_bib48",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1016/j.cellin.2022.100068",
"article-title": "Atlas of interactions between SARS-CoV-2 macromolecules and host proteins",
"author": "Li",
"doi-asserted-by": "crossref",
"issue": "1",
"journal-title": "Cell Insight",
"key": "10.1016/j.cellin.2025.100250_bib49",
"volume": "2",
"year": "2023"
},
{
"DOI": "10.1038/s41591-020-0901-9",
"article-title": "Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19",
"author": "Liao",
"doi-asserted-by": "crossref",
"first-page": "842",
"issue": "6",
"journal-title": "Nature Medicine",
"key": "10.1016/j.cellin.2025.100250_bib50",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1016/j.pccm.2023.10.003",
"article-title": "Mechanisms of long COVID: An updated review",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "231",
"issue": "4",
"journal-title": "Chin. Med. J. Pulm. Crit. Care Med",
"key": "10.1016/j.cellin.2025.100250_bib51",
"volume": "1",
"year": "2023"
},
{
"DOI": "10.1038/s41573-021-00154-z",
"article-title": "Channelling inflammation: Gasdermins in physiology and disease",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "384",
"issue": "5",
"journal-title": "Nature Reviews Drug Discovery",
"key": "10.1016/j.cellin.2025.100250_bib52",
"volume": "20",
"year": "2021"
},
{
"article-title": "SARS-CoV-2 is sensitive to type I interferon pretreatment",
"author": "Lokugamage",
"first-page": "770",
"issue": "7",
"journal-title": "Nature Microbiology",
"key": "10.1016/j.cellin.2025.100250_bib53",
"volume": "5",
"year": "2020"
},
{
"article-title": "Monocytes and macrophages in COVID-19: Friends and foes",
"author": "Meidaninikjeh",
"journal-title": "Life Sciences",
"key": "10.1016/j.cellin.2025.100250_bib54",
"volume": "276",
"year": "2021"
},
{
"DOI": "10.4049/jimmunol.164.12.6166",
"article-title": "M-1/M-2 macrophages and the Th1/Th2 paradigm",
"author": "Mills",
"doi-asserted-by": "crossref",
"first-page": "6166",
"issue": "12",
"journal-title": "The Journal of Immunology",
"key": "10.1016/j.cellin.2025.100250_bib55",
"volume": "164",
"year": "2000"
},
{
"article-title": "SARS-CoV-2 ORF6 antagonizes interferon signaling by sequestering STAT1 and STAT2 in the endoplasmic reticulum",
"author": "Miorin",
"first-page": "5148",
"issue": "1",
"journal-title": "Nature Communications",
"key": "10.1016/j.cellin.2025.100250_bib56",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1016/j.cell.2021.01.004",
"article-title": "Multi-organ proteomic landscape of COVID-19 autopsies",
"author": "Nie",
"doi-asserted-by": "crossref",
"first-page": "775",
"issue": "3",
"journal-title": "Cell",
"key": "10.1016/j.cellin.2025.100250_bib57",
"volume": "184",
"year": "2021"
},
{
"DOI": "10.1016/j.it.2022.08.001",
"article-title": "Afucosylated IgG responses in humans-structural clues to the regulation of humoral immunity",
"author": "Oosterhoff",
"doi-asserted-by": "crossref",
"first-page": "800",
"issue": "10",
"journal-title": "Trends in Immunology",
"key": "10.1016/j.cellin.2025.100250_bib58",
"volume": "43",
"year": "2022"
},
{
"DOI": "10.1038/s41586-020-03065-y",
"article-title": "Genetic mechanisms of critical illness in COVID-19",
"author": "Pairo-Castineira",
"doi-asserted-by": "crossref",
"first-page": "92",
"journal-title": "Nature",
"key": "10.1016/j.cellin.2025.100250_bib59",
"volume": "591",
"year": "2021"
},
{
"DOI": "10.1038/s41467-021-25015-6",
"article-title": "SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation",
"author": "Pan",
"doi-asserted-by": "crossref",
"first-page": "4664",
"issue": "1",
"journal-title": "Nature Communications",
"key": "10.1016/j.cellin.2025.100250_bib60",
"volume": "12",
"year": "2021"
},
{
"DOI": "10.1016/j.chom.2020.05.008",
"article-title": "Type I and type III interferons-induction, signaling, evasion, and application to combat COVID-19",
"author": "Park",
"doi-asserted-by": "crossref",
"first-page": "870",
"issue": "6",
"journal-title": "Cell Host & Microbe",
"key": "10.1016/j.cellin.2025.100250_bib61",
"volume": "27",
"year": "2020"
},
{
"DOI": "10.1186/1465-9921-6-75",
"article-title": "CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II",
"author": "Pechkovsky",
"doi-asserted-by": "crossref",
"first-page": "75",
"issue": "1",
"journal-title": "Respiratory Research",
"key": "10.1016/j.cellin.2025.100250_bib62",
"volume": "6",
"year": "2005"
},
{
"DOI": "10.1093/cid/ciaa248",
"article-title": "Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China",
"author": "Qin",
"doi-asserted-by": "crossref",
"first-page": "762",
"issue": "15",
"journal-title": "Clinical Infectious Diseases",
"key": "10.1016/j.cellin.2025.100250_bib63",
"volume": "71",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(21)00676-0",
"article-title": "Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial",
"doi-asserted-by": "crossref",
"first-page": "1637",
"issue": "10285",
"journal-title": "Lancet",
"key": "10.1016/j.cellin.2025.100250_bib64",
"volume": "397",
"year": "2021"
},
{
"DOI": "10.1164/rccm.201712-2410OC",
"article-title": "Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis",
"author": "Reyfman",
"doi-asserted-by": "crossref",
"first-page": "1517",
"issue": "12",
"journal-title": "American Journal of Respiratory and Critical Care Medicine",
"key": "10.1016/j.cellin.2025.100250_bib65",
"volume": "199",
"year": "2019"
},
{
"DOI": "10.1038/s41467-019-09397-2",
"article-title": "Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation",
"author": "Rogers",
"doi-asserted-by": "crossref",
"first-page": "1689",
"issue": "1",
"journal-title": "Nature Communications",
"key": "10.1016/j.cellin.2025.100250_bib66",
"volume": "10",
"year": "2019"
},
{
"DOI": "10.1007/s00134-020-05991-x",
"article-title": "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China",
"author": "Ruan",
"doi-asserted-by": "crossref",
"first-page": "846",
"issue": "5",
"journal-title": "Intensive Care Medicine",
"key": "10.1016/j.cellin.2025.100250_bib67",
"volume": "46",
"year": "2020"
},
{
"article-title": "Baricitinib is first approved COVID-19 immunomodulatory treatment",
"author": "Rubin",
"first-page": "2281",
"issue": "23",
"journal-title": "JAMA",
"key": "10.1016/j.cellin.2025.100250_bib68",
"volume": "327",
"year": "2022"
},
{
"author": "Schifanella",
"key": "10.1016/j.cellin.2025.100250_bib69"
},
{
"DOI": "10.1083/jcb.201602089",
"article-title": "The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation",
"author": "Sharma",
"doi-asserted-by": "crossref",
"first-page": "617",
"issue": "6",
"journal-title": "The Journal of Cell Biology",
"key": "10.1016/j.cellin.2025.100250_bib70",
"volume": "213",
"year": "2016"
},
{
"DOI": "10.1002/cyto.a.24285",
"article-title": "Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages",
"author": "Song",
"doi-asserted-by": "crossref",
"first-page": "136",
"issue": "2",
"journal-title": "Cytometry, Part A",
"key": "10.1016/j.cellin.2025.100250_bib71",
"volume": "103",
"year": "2023"
},
{
"DOI": "10.1038/s41392-022-01039-2",
"article-title": "Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants",
"author": "Sun",
"doi-asserted-by": "crossref",
"first-page": "202",
"issue": "1",
"journal-title": "Signal Transduction and Targeted Therapy",
"key": "10.1016/j.cellin.2025.100250_bib72",
"volume": "7",
"year": "2022"
},
{
"DOI": "10.1038/s41586-022-04865-0",
"article-title": "Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination",
"author": "Suryawanshi",
"doi-asserted-by": "crossref",
"first-page": "351",
"issue": "7918",
"journal-title": "Nature",
"key": "10.1016/j.cellin.2025.100250_bib73",
"volume": "607",
"year": "2022"
},
{
"DOI": "10.1038/s41577-020-0311-8",
"article-title": "The trinity of COVID-19: Immunity, inflammation and intervention",
"author": "Tay",
"doi-asserted-by": "crossref",
"first-page": "363",
"issue": "6",
"journal-title": "Nature Reviews Immunology",
"key": "10.1016/j.cellin.2025.100250_bib74",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.1038/s41467-023-37425-9",
"article-title": "TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques",
"author": "Upadhyay",
"doi-asserted-by": "crossref",
"first-page": "1914",
"issue": "1",
"journal-title": "Nature Communications",
"key": "10.1016/j.cellin.2025.100250_bib76",
"volume": "14",
"year": "2023"
},
{
"DOI": "10.1016/j.pccm.2024.02.005",
"article-title": "Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivors",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "48",
"issue": "1",
"journal-title": "Chin. Med. J. Pulm. Crit. Care Med",
"key": "10.1016/j.cellin.2025.100250_bib78",
"volume": "2",
"year": "2024"
},
{
"article-title": "Alveolar macrophage activation and polarization in COVID-19: A systematic review of the current evidence",
"author": "Wang",
"journal-title": "Frontiers in Immunology",
"key": "10.1016/j.cellin.2025.100250_bib79",
"volume": "12",
"year": "2021"
},
{
"DOI": "10.1016/j.chom.2020.07.005",
"article-title": "Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "455",
"issue": "3",
"journal-title": "Cell Host & Microbe",
"key": "10.1016/j.cellin.2025.100250_bib80",
"volume": "28",
"year": "2020"
},
{
"DOI": "10.1038/s41392-022-00977-1",
"article-title": "Airway administration of bisphosphate and dexamethasone inhibits SARS-CoV-2 variant infection by targeting alveolar macrophages",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "116",
"issue": "1",
"journal-title": "Signal Transduction and Targeted Therapy",
"key": "10.1016/j.cellin.2025.100250_bib81",
"volume": "7",
"year": "2022"
},
{
"DOI": "10.1126/science.abb9983",
"article-title": "Site-specific glycan analysis of the SARS-CoV-2 spike",
"author": "Watanabe",
"doi-asserted-by": "crossref",
"first-page": "330",
"issue": "6501",
"journal-title": "Science",
"key": "10.1016/j.cellin.2025.100250_bib82",
"volume": "369",
"year": "2020"
},
{
"DOI": "10.1128/JVI.80.10.5059-5064.2006",
"article-title": "Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses",
"author": "Weber",
"doi-asserted-by": "crossref",
"first-page": "5059",
"issue": "10",
"journal-title": "Journal of Virology",
"key": "10.1016/j.cellin.2025.100250_bib83",
"volume": "80",
"year": "2006"
},
{
"DOI": "10.1001/jamainternmed.2020.0994",
"article-title": "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China",
"author": "Wu",
"doi-asserted-by": "crossref",
"first-page": "934",
"issue": "7",
"journal-title": "JAMA Internal Medicine",
"key": "10.1016/j.cellin.2025.100250_bib84",
"volume": "180",
"year": "2020"
},
{
"DOI": "10.1016/j.cellin.2023.100145",
"article-title": "ACE2-using merbecoviruses: Further evidence of convergent evolution of ACE2 recognition by NeoCoV and other MERS-CoV related viruses",
"author": "Xiong",
"doi-asserted-by": "crossref",
"issue": "1",
"journal-title": "Cell Insight",
"key": "10.1016/j.cellin.2025.100250_bib85",
"volume": "3",
"year": "2024"
},
{
"DOI": "10.4049/jimmunol.2000513",
"article-title": "Inflammasomes and pyroptosis as therapeutic targets for COVID-19",
"author": "Yap",
"doi-asserted-by": "crossref",
"first-page": "307",
"issue": "2",
"journal-title": "The Journal of Immunology",
"key": "10.1016/j.cellin.2025.100250_bib86",
"volume": "205",
"year": "2020"
},
{
"DOI": "10.1038/s41577-019-0182-z",
"article-title": "Interferon-λ orchestrates innate and adaptive mucosal immune responses",
"author": "Ye",
"doi-asserted-by": "crossref",
"first-page": "614",
"issue": "10",
"journal-title": "Nature Reviews Immunology",
"key": "10.1016/j.cellin.2025.100250_bib87",
"volume": "19",
"year": "2019"
},
{
"DOI": "10.1016/j.bbrc.2020.04.136",
"article-title": "Biochemical characterization of SARS-CoV-2 nucleocapsid protein",
"author": "Zeng",
"doi-asserted-by": "crossref",
"first-page": "618",
"issue": "3",
"journal-title": "Biochemical and Biophysical Research Communications",
"key": "10.1016/j.cellin.2025.100250_bib88",
"volume": "527",
"year": "2020"
},
{
"DOI": "10.7326/M20-0533",
"article-title": "Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "629",
"issue": "9",
"journal-title": "Annals of Internal Medicine",
"key": "10.1016/j.cellin.2025.100250_bib89",
"volume": "172",
"year": "2020"
},
{
"DOI": "10.1016/j.pccm.2022.12.002",
"article-title": "Pulmonary fibrosis: A short-or long-term sequelae of severe COVID-19?",
"author": "Zheng",
"doi-asserted-by": "crossref",
"first-page": "77",
"issue": "2",
"journal-title": "Chin. Med. J. Pulm. Crit. Care Med",
"key": "10.1016/j.cellin.2025.100250_bib90",
"volume": "1",
"year": "2023"
},
{
"DOI": "10.3389/fimmu.2020.01061",
"article-title": "Interferon-α2b treatment for COVID-19",
"author": "Zhou",
"doi-asserted-by": "crossref",
"first-page": "1061",
"journal-title": "Frontiers in Immunology",
"key": "10.1016/j.cellin.2025.100250_bib91",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)30566-3",
"article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: A retrospective cohort study",
"author": "Zhou",
"doi-asserted-by": "crossref",
"first-page": "1054",
"issue": "10229",
"journal-title": "Lancet",
"key": "10.1016/j.cellin.2025.100250_bib92",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1038/s41590-024-02072-9",
"article-title": "Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs",
"author": "Zhu",
"doi-asserted-by": "crossref",
"first-page": "459",
"issue": "3",
"journal-title": "Nature Immunology",
"key": "10.1016/j.cellin.2025.100250_bib93",
"volume": "26",
"year": "2025"
}
],
"reference-count": 90,
"references-count": 90,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S2772892725000240"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome",
"type": "journal-article",
"update-policy": "https://doi.org/10.1016/elsevier_cm_policy",
"volume": "4"
}
